People · Operator
Named in public records as an officer, director or promoter · active 2020–2020 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Atea Pharmaceuticals, Inc. | — | Biotechnology | Series D+ | $175.9M | $4.4B | 2020 |
Isaac Cheng, M.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Isaac Cheng, M.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| BIHUA CHEN | 1 | 14 |
| Gerald Chan | 1 | 13 |
| Franklin Berger | 1 | 7 |
| Fan Yu | 1 | 4 |
| Jean-Pierre Sommadossi | 1 | 3 |
| Frank Yu | 1 | 3 |
| Grigory Borisenko | 1 | 3 |
| Bruce Polsky | 1 | 1 |
| Bruno Lucidi | 1 | 1 |
| Jean-Pierre Sommadossi, Ph.D. | 1 | 1 |
| Andrea Corcoran | 1 | 1 |
| Evgeny Zatsev | 1 | 1 |
| Andrew Hack, M.D., Ph.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.